Viewing Study NCT00608361


Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-02-27 @ 7:56 AM
Study NCT ID: NCT00608361
Status: COMPLETED
Last Update Posted: 2015-07-02
First Post: 2008-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module